Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

Featured Open Trial

This important trial funded by DCP is open and actively accruing new participants. More specific information can be found in the links below.

Preventing High-Risk Adenomas and Second Cancers in Colon Cancer Survivors (S0820)

In this trial, people who have undergone curative surgery for stage 0-3 colon cancer, with or without adjuvant chemotherapy, will be randomly assigned to take sulindac and a placebo, eflornithine and a placebo, both sulindac and eflornithine, or two placebo pills for 36 months. Doctors will closely monitor all trial participants throughout the study to detect the recurrence of high-risk adenomas or the development of new colon or rectal cancers.

S0820 Protocol

Featured Clinical Trial Summary

Information for Potential Participants (from SWOG) Exit Disclaimer


Back to Top